Obesity is a major risk factor for obstructive sleep apnea (OSA), contributing to airway obstruction, reduced lung function, and increased disease severity. This clinical session from Sleep DownUnder 2025 explores the complex relationship between obesity and OSA, highlighting the physiological mechanisms linking excess weight to sleep-disordered breathing. It also reviews the latest advances in weight management strategies, including lifestyle interventions, bariatric surgery, and pharmacological treatments such as GLP-1 receptor agonists.

Presentations

• OSA and obesity: nuts and bolts (epidemiology and endotypes/phenotypes) - Danny Eckert
• Obesity and weight loss: endocrinologist/obesity physician point of view - Samantha Hocking
• Obesity and weight loss in OSA: sleep physician point of view - Matthew Naughton
• Should GLP-1 agonists be first line therapy in obese OSA patients? - Sanjay Patel
• Panel discussion

This learning activity is $30 for ASA members and $60 for others.

1 CPD point

• Training Hours: 1.50